AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Axonics Modulation Technologies Inc (NASDAQ:AXNX)
-- USD
0.000 0.000%Sponsored Reports
Loading...
| Previous Close (in USD) | 70.98 |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 71.050/55.090 |
| EBITDA (in USD) | 5.273M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -0.10 |
| Total Assets (in USD) | 719.923M |
|---|---|
| Total Liabilities (in USD) | 82.359M |
| Revenue TTM (in USD) | 431.902M |
| Cash (in USD) | 104.811M |
| Market Cap (in USD) | 3,627.731 M |
| Revenue Per Share TTM | 8.534 |
| Gross Profit TTM (in USD) | 197.665M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Axonics Modulation Technologies Inc
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. As of November 15, 2024, Axonics, Inc. operates as a subsidiary of Boston Scientific Corporation.
Employees: 797
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Raymond W. Cohen | CEO & Director | 1959 |
| 2. | Mr. Danny L. Dearen | Pres & CFO | 1963 |
| 3. | Mr. Rinda K. Sama | Chief Operating Officer | 1980 |
| 4. | Dr. John Woock Ph.D. | Exec. VP, Chief Marketing & Strategy Officer | 1984 |
| 5. | Mr. Alfred J. Ford Jr. | Chief Commercial Officer | 1971 |
| 6. | Mr. Guangqiang Jiang Ph.D. | Chief Technology Officer | 1974 |
| 7. | Mr. Neil Bhalodkar | VP of Investor Relations | NA |
| 8. | Mr. Aaron Pettit | Gen. Counsel & Chief Compliance Officer | NA |
| 9. | Mr. Michael V. Williamson Esq., J.D. | Sr. VP, Gen. & IP Counsel | 1972 |
| 10. | Dr. Karen L. Noblett M.A.S., M.D. | Chief Medical Officer | 1964 |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+0.880 0.944% | 93.86 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
+16.600 5.251% | 317.75 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+0.460 0.571% | 79.84 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.030 0.068% | 44.4 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -62.316M | -79.285M | -54.914M | -79.934M | -32.482M |
| Minority Interest | - | - | - | - | - |
| Net Income | -59.698M | -80.067M | -54.915M | -79.935M | -32.483M |
| Selling General Administrative | 40.238M | 32.785M | 25.551M | 19.076M | 9.362M |
| Gross Profit | 197.665M | 115.718M | 67.091M | 7.33M | 0.351M |
| Reconciled Depreciation | 11.721M | 7.241M | 1.741M | 1.191M | 0.946M |
| Ebit | -42.385M | -67.394M | -53.76M | -80.599M | -32.085M |
| Ebitda | -27.869M | -60.113M | -52.999M | -77.625M | -31.139M |
| Depreciation And Amortization | 14.516M | 7.281M | 0.761M | 2.974M | 0.946M |
| Operating Income | -42.385M | -67.394M | -53.76M | -80.599M | -32.137M |
| Other Operating Expenses | 316.087M | 247.684M | 165.295M | 94.419M | 32.844M |
| Interest Expense | 2.434M | 7.426M | 1.874M | 2.309M | 1.343M |
| Tax Provision | -2.618M | 0.782M | 0.001M | 0.001M | 0.001M |
| Interest Income | 5.133M | 0.04M | 0.761M | 2.974M | 0.998M |
| Net Interest Income | 2.699M | -7.386M | -1.113M | 0.665M | -0.345M |
| Income Tax Expense | -2.618M | 0.782M | 0.001M | 0.001M | 0.001M |
| Total Revenue | 273.702M | 180.29M | 111.535M | 13.82M | 0.707M |
| Total Operating Expenses | 240.05M | 183.112M | 120.851M | 87.929M | 32.488M |
| Cost Of Revenue | 76.037M | 64.572M | 44.444M | 6.49M | 0.356M |
| Total Other Income Expense Net | -19.931M | -11.891M | -1.154M | 0.665M | -0.345M |
| Net Income From Continuing Ops | -59.698M | -80.067M | -54.915M | -79.935M | -32.483M |
| Net Income Applicable To Common Shares | -59.698M | -80.067M | -54.915M | -79.935M | -32.483M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 719.923M | 659.353M | 547.945M | 342.206M | 219.822M |
| Intangible Assets | 81.375M | 86.253M | 106.469M | 0.196M | 0.311M |
| Other Current Assets | 9.279M | 7.282M | 6.449M | 5.435M | 4.468M |
| Total Liab | 82.359M | 89.214M | 65.507M | 54.836M | 36.819M |
| Total Stockholder Equity | 637.564M | 570.139M | 482.438M | 287.37M | 183.003M |
| Other Current Liab | 25.587M | 54.615M | 17.848M | 12.632M | 5.549M |
| Common Stock | 0.005M | 0.005M | 0.005M | 0.004M | 0.003M |
| Capital Stock | 0.005M | 0.005M | 0.005M | 0.004M | 0.003M |
| Retained Earnings | -380.352M | -374.264M | -314.566M | -234.499M | -179.584M |
| Good Will | 99.417M | 94.414M | 105.51M | - | - |
| Other Assets | 0M | 0.613M | 7.734M | 7.736M | 0.584M |
| Cash | 104.811M | 238.846M | 220.878M | 241.181M | 171.082M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 45.816M | 65.247M | 26.868M | 45.682M | 12.033M |
| Current Deferred Revenue | - | - | - | - | - |
| Net Debt | -77.194M | -229.729M | -210.46M | -209.637M | -145.694M |
| Short Term Debt | 1.777M | 1.562M | 1.366M | 22.39M | 0.602M |
| Short Long Term Debt | - | 32.6M | - | 21.11M | - |
| Short Long Term Debt Total | 27.617M | 9.117M | 10.418M | 31.544M | 25.388M |
| Other Stockholder Equity | 1033.778M | 969.545M | 803.559M | 522.296M | 363.012M |
| Property Plant Equipment | - | 6.798M | 6.915M | 6.328M | 7.247M |
| Total Current Assets | 491.422M | 465.075M | 321.317M | 327.946M | 211.68M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 240.149M | 118.365M | - | 0M | 12.592M |
| Net Receivables | 57.243M | 44.817M | 29.044M | 18.27M | 7.879M |
| Long Term Debt | - | - | - | - | 20.336M |
| Inventory | 79.94M | 55.765M | 64.946M | 63.06M | 15.659M |
| Accounts Payable | 18.452M | 9.07M | 7.654M | 10.66M | 5.882M |
| Accumulated Other Comprehensive Income | -15.867M | -25.147M | -6.56M | -0.431M | -0.428M |
| Non Currrent Assets Other | 1.735M | 6.813M | 7.734M | 7.736M | 4.784M |
| Non Current Assets Total | 228.501M | 194.278M | 226.628M | 14.26M | 8.142M |
| Capital Lease Obligations | 27.617M | 9.117M | 10.418M | 10.434M | 5.052M |
| Long Term Debt Total | - | - | - | - | 20.336M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -118.131M | -143.002M | 12.592M | 45.287M | -60.05M |
| Total Cashflows From Investing Activities | -120.354M | -143.002M | 9.654M | 45.287M | -60.05M |
| Total Cash From Financing Activities | 133.968M | 170.513M | 144.19M | 110.955M | 165.342M |
| Net Income | -59.698M | -80.067M | -54.915M | -79.935M | -32.483M |
| Change In Cash | 17.968M | -20.303M | 70.099M | 72.776M | 73.908M |
| Begin Period Cash Flow | 220.878M | 241.181M | 171.082M | 98.306M | 24.398M |
| End Period Cash Flow | 238.846M | 220.878M | 241.181M | 171.082M | 98.306M |
| Total Cash From Operating Activities | 3.191M | -47.306M | -83.742M | -83.454M | -31.37M |
| Depreciation | 11.721M | 9.126M | 1.741M | 1.191M | 0.946M |
| Other Cashflows From Investing Activities | - | -140.741M | - | 46.626M | -58.822M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | 8.423M | -1.108M | -47.353M | -11.986M | -2.255M |
| Sale Purchase Of Stock | 133.968M | 185.463M | -9.013M | -7.141M | -12.623M |
| Other Cashflows From Financing Activities | 5.47M | 70.379M | -5.31M | -6.635M | 39.965M |
| Capital Expenditures | 2.223M | 2.261M | 2.938M | 1.339M | 1.228M |
| Change In Working Capital | -2.931M | -9.811M | -47.033M | -14.378M | -2.855M |
| Other Non Cash Items | 22.265M | 7.7M | 0.939M | 0.873M | 2.162M |
| Free Cash Flow | 0.968M | -49.567M | -86.68M | -84.793M | -32.598M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 1 year ago | 1636815 |
| 2. | Vanguard Small Cap Index | 1 year ago | 1281794 |
| 3. | The Merger Fund A | 1 year ago | 1126557 |
| 4. | Fidelity Canadian Large Cap Sr B | 1 year ago | 1015622 |
| 5. | Canada Life US Small-Mid Cap Growth A | 1 year ago | 912097 |
| 6. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 735301 |
| 7. | Vanguard Small Cap Growth Index Inv | 1 year ago | 704283 |
| 8. | Fidelity Canadian Large Cp Mlt Ast Bs O | 1 year ago | 640000 |
| 9. | Xtrackers MSCI USA Swap ETF 1C | 1 year ago | 560752 |
| 10. | Fidelity Small Cap Index | 1 year ago | 519208 |
| 11. | Arbitrage R | 1 year ago | 471594 |
| 12. | Man Event Driven Alternative IN USD | 1 year ago | 434836 |
| 13. | AQR Diversified Arbitrage I | 1 year ago | 416258 |
| 14. | Fidelity Extended Market Index | 1 year ago | 286279 |
| 15. | State St Russell Sm/Mid Cp® Indx NL Cl C | 1 year ago | 277162 |
| 16. | Vanguard Russell 2000 ETF | 1 year ago | 232008 |
| 17. | Fidelity Monthly Income Series F | 1 year ago | 208444 |
| 18. | AB Merger Arbitrage S1 USD | 1 year ago | 206793 |
| 19. | Virtus Westchester Event-Driven Fd I | 1 year ago | 202967 |
| 20. | DFA US Micro Cap I | 1 year ago | 200252 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Fidelity International Ltd | 1 year ago | 2044722 |
| 2. | Westchester Capital Management LLC | 1 year ago | 1450381 |
| 3. | Omni Event Management Ltd | 1 year ago | 1360463 |
| 4. | NORGES BANK | 1 year ago | 1271656 |
| 5. | Mackenzie Investments | 1 year ago | 1252857 |
| 6. | Geode Capital Management, LLC | 1 year ago | 1200745 |
| 7. | Magnetar Financial LLC | 1 year ago | 1190335 |
| 8. | State Street Corp | 1 year ago | 1184492 |
| 9. | Soros Fund Management LLC | 1 year ago | 1050001 |
| 10. | Qube Research & Technologies | 1 year ago | 899317 |
| 11. | AllianceBernstein L.P. | 1 year ago | 879161 |
| 12. | Cnh Partners, LLC | 1 year ago | 853820 |
| 13. | Dimensional Fund Advisors, Inc. | 1 year ago | 839860 |
| 14. | Millennium Management LLC | 1 year ago | 836418 |
| 15. | Deutsche Bank AG | 1 year ago | 716919 |
| 16. | Water Island Capital LLC | 1 year ago | 691839 |
| 17. | JPMorgan Chase & Co | 1 year ago | 657206 |
| 18. | Vanguard Group Inc | 1 year ago | 5064595 |
| 19. | BlackRock Inc | 1 year ago | 4341508 |
| 20. | Eckert Corp | 1 year ago | 2178157 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...